Back

Deficiency of CD239 increases susceptibility to chronic kidney disease

Kikkawa, Y.; Iwanami, J.; Hamada, K.; Yamada, Y.; Sasaki, T.; Tanaka, M.; Kanagawa, M.

2026-06-03 pathology
10.64898/2026.05.31.728029 bioRxiv
Show abstract

CD239, also known as Lutheran blood group glycoprotein (Lu) or basal cell adhesion molecule (B-CAM), is a transmembrane protein belonging to the immunoglobulin superfamily (IgSF). CD239 serves as a specific receptor for laminin 5, a subunit of laminin-511/-521, which are major components of renal basement membranes. A previous study of another group demonstrated that CD239-null mice are healthy and develop normally. Although no alteration in renal function was observed, most glomeruli in the mutant kidneys exhibited morphological abnormalities. In this study, we investigated the role of CD239 in renal tubules. We examined the distribution of CD239 using renal tubule-specific markers. CD239 was localized to the Henles loop, distal tubule, and collecting duct, but not to the proximal tubule. Next, we analyzed the localization of renal tubular molecules in CD239-null mice. The localization of uromodulin (UMOD) and Na-K-Cl cotransporter (NKCC2) was disrupted in the distal tubules lacking CD239, suggesting that CD239 plays a role in maintaining the polarity of renal epithelial cells. Furthermore, to examine the stability of the distal tubules, CD239-null mice were subjected to chronic kidney disease (CKD) using an adenine-rich diet. Blood analysis revealed that CD239-null mice fed an adenine diet readily developed CKD. Adenine-fed null mice exhibited more marked histological injury along the distal tubules compared to that by controls. These results indicate that CD239 is essential not only for maintaining cellular polarity but also for ensuring the stability of the distal tubules. Although CD239-null humans exhibit no obvious associated pathology, it could be a predisposition to CKD.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 4%
24.1%
2
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.1%
10.8%
3
Scientific Reports
3102 papers in training set
Top 14%
6.8%
4
Kidney360
22 papers in training set
Top 0.2%
4.6%
5
Frontiers in Pharmacology
100 papers in training set
Top 0.7%
3.8%
50% of probability mass above
6
Frontiers in Genetics
197 papers in training set
Top 2%
3.1%
7
International Journal of Molecular Sciences
453 papers in training set
Top 4%
2.2%
8
The American Journal of Pathology
31 papers in training set
Top 0.1%
2.2%
9
Frontiers in Molecular Biosciences
100 papers in training set
Top 0.9%
2.2%
10
Physiological Reports
35 papers in training set
Top 0.4%
1.9%
11
Heliyon
146 papers in training set
Top 1%
1.9%
12
Bioscience Reports
25 papers in training set
Top 0.4%
1.8%
13
Human Molecular Genetics
130 papers in training set
Top 1%
1.8%
14
Cancers
200 papers in training set
Top 3%
1.8%
15
The FASEB Journal
175 papers in training set
Top 1%
1.6%
16
Cells
232 papers in training set
Top 3%
1.3%
17
Virology
56 papers in training set
Top 0.5%
1.0%
18
Biochemical and Biophysical Research Communications
78 papers in training set
Top 1%
1.0%
19
Gene
41 papers in training set
Top 1%
1.0%
20
Journal of Cellular Physiology
21 papers in training set
Top 0.4%
1.0%
21
Animals
20 papers in training set
Top 0.7%
0.8%
22
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.8%
23
Journal of Virology
456 papers in training set
Top 3%
0.8%
24
Viruses
318 papers in training set
Top 4%
0.8%
25
Journal of the American Society of Nephrology
52 papers in training set
Top 0.5%
0.8%
26
eLife
5422 papers in training set
Top 62%
0.5%
27
JCI Insight
241 papers in training set
Top 9%
0.5%
28
Transboundary and Emerging Diseases
34 papers in training set
Top 1.0%
0.5%
29
Kidney International Reports
14 papers in training set
Top 0.3%
0.5%
30
Frontiers in Oncology
95 papers in training set
Top 4%
0.5%